Due to the lack of funding and economically weaker patient population new antimalarials need to be cost-effective. The concept of AMCS can be harnessed to achieve this goal. Although there are inherent limitations associated with using hard cut offs and existing computational methodologies, the AMCS has strong potential to identify novel chemical matter for designing antimalarials that are resilient to resistance development.